Virus-Specific Stem Cell Memory CD8+ T Cells May Indicate a Long-Term Protection against Evolving SARS-CoV-2
Diagnostics · 28.03.2023 · 13 (7) · 1280
DOI: 10.3390/diagnostics13071280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 28.03.2023. Verfasst von Milena Aleksova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, National Center of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, ORFDO NIH HHS, Bulgarian National Science Fund.
Abstract (Originalsprache)
Immune memory to SARS-CoV-2 is key for establishing herd immunity and limiting the spread of the virus. The duration and qualities of T-cell-mediated protection in the settings of constantly evolving pathogens remain an open question. We conducted a cross-sectional study of SARS-CoV-2-specific CD4+ and CD8+ T-cell responses at several time points over 18 months (30–750 days) post mild/moderate infection with the aim to identify suitable methods and biomarkers for evaluation of long-term T-cell memory in peripheral blood. Included were 107 samples from 95 donors infected during the periods 03/2020–07/2021 and 09/2021–03/2022, coinciding with the prevalence of B.1.1.7 (alpha) and B.1.617.2 (delta) variants in Bulgaria. SARS-CoV-2-specific IFNγ+ T cells were measured in ELISpot in parallel with flow cytometry detection of AIM+ total and stem cell-like memory (TSCM) CD4+ and CD8+ T cells after in vitro stimulation with peptide pools corresponding to the original and delta variants. We show that, unlike IFNγ+ T cells, AIM+ virus-specific CD4+ and CD8+ TSCM are more adequate markers of T cell memory, even beyond 18 months post-infection. In the settings of circulating and evolving viruses, CD8+ TSCM is remarkably stable, back-differentiated into effectors, and delivers immediate protection, regardless of the initial priming strain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunology Department, National Center of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria.
- Department of Infectious Diseases, Military Medical Academy, 1000 Sofia, Bulgaria.
- Specialized Hospital for Active Treatment of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria.
- Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), Conl Public Health, University of California San Diego (UCSD), San Diego, CA 92037, USA.
- Department of Pathology, University of California La Jolla, San Diego, CA 92093, USA.
ORCID-Profile: Milena Aleksova, Radoslava Emilova, Magdalena Baymakova, Nina Yancheva, Anelia Zasheva, Alba Grifoni, Daniela Weiskopf, Alessandro Sette
Förderung
- NIAID NIH HHS
- ORFDO NIH HHS
- Bulgarian National Science Fund
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Aleksova, M., Todorova, Y., Emilova, R., Baymakova, M., Yancheva, N., Andonova, R., Zasheva, A., Grifoni, A., Weiskopf, D., Sette, A., & Nikolova, M. (2023). Virus-Specific Stem Cell Memory CD8+ T Cells May Indicate a Long-Term Protection against Evolving SARS-CoV-2. Diagnostics, 13(7), 1280. https://doi.org/10.3390/diagnostics13071280
Vancouver
Aleksova M, Todorova Y, Emilova R, Baymakova M, Yancheva N, Andonova R, et al. Virus-Specific Stem Cell Memory CD8+ T Cells May Indicate a Long-Term Protection against Evolving SARS-CoV-2. Diagnostics. 2023;13(7):1280. doi:10.3390/diagnostics13071280
BibTeX
@article{Aleksova2023,
author = {Aleksova, Milena and Todorova, Yana and Emilova, Radoslava and Baymakova, Magdalena and Yancheva, Nina and Andonova, Radina and Zasheva, Anelia and Grifoni, Alba and Weiskopf, Daniela and Sette, Alessandro and Nikolova, Maria},
title = {Virus-Specific Stem Cell Memory CD8+ T Cells May Indicate a Long-Term Protection against Evolving SARS-CoV-2},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {7},
pages = {1280},
doi = {10.3390/diagnostics13071280}
}
EUVIMED